Prudential Jennison Health Scien: (MF: PHLAX)
NAV
$35.79
NAV Day Change
0.20 (0.56%)
May 23 06:05 PM ET
General Information As Of 04/30/13
| %Yield | 0.11 |
| %SEC Yield | NA |
| %YTD Return (as of 04/30/13) | 24.43 |
| Objective* | Equity - Sector Health |
| Peer* | HL MG |
Portfolio Statistics
| %Unrealized Gain YTD | 26.91 |
| Net Assets (Mil $) 04/30/2013 | 688.75 |
| %Turnover 04/30/2013 | 47.00 |
Fees
| %Max Sales Load | 5.50 |
| %Min Sales Load | .00 |
| %Max Deferred Load | NA |
Expenses
| %Max 12b-1 Fee | 0.30 |
| %Max Management Fee | 0.75 |
| Redemption Fee | NA |
| Expense Ratio | 1.23 |
Allocation
| Large Growth | 61.77 |
| Large Value | 0.00 |
| Small Growth | 0.00 |
| Small Value | 0.00 |
| Foreign Stock | 0.00 |
| Emerging Market | 0.00 |
| Precious Metal | 0.00 |
| Intermediate Bond | 0.00 |
| Foreign Bond | 0.00 |
| High Yield Bond | 0.00 |
Portfolio Information
Composition
| As of 02/28/2013 | %of Net Assets |
| Stock | 93.67 |
| Cash | 18.15 |
| Bonds | 0.00 |
| Preferred | 1.00 |
| Convertibles | 0.07 |
| Foreign Stock | 11.52 |
| Foreign Bonds | 0.00 |
| Hedge | 0.00 |
| Other | -12.88 |
Sector / Country Weightings
| As of 04/30/2013 | % of Portfolio |
|---|---|
| Health | 61.07 |
| Other | 10.24 |
| Services | 9.19 |
| Finance | 8.92 |
| Industrial Cyclical | 5.02 |
| Technology | 3.69 |
| Retail Trade | 1.87 |
Portfolio Holdings
| Top Equity Holdings (As of 11/30/2012) | % of Portfolio | Value (Mil$) |
|---|---|---|
| BIOMARIN PHARMACEUTICAL | 6.96 | 88.57 |
| ALEXION PHARMACEUTICALS I | 6.33 | 80.56 |
| VERTEX PHARMACEUTICALS IN | 4.23 | 53.74 |
| MEDIVATION INC | 4.22 | 53.62 |
| PFIZER INC | 4.18 | 53.21 |
| AMARIN CORP PLC | 3.95 | 50.22 |
| UNITEDHEALTH GROUP INC | 3.39 | 43.14 |
| ARIAD PHARMACEUTICALS INC | 3.32 | 42.27 |
| ONYX PHARMACEUTICALS INC | 3.00 | 38.18 |
Contact Information
| Family | Prudential |
| Addrerss | PO Box 9655 Providence, RI 02940 |
| Phone | 800 225-1852 |
Zacks Premium Research
Zacks Mutual Fund Rank: 3 - Hold 
| #3 |
Fund Description
Incepted in June 1999, this fund is managed by Prudential Investment. The objective of this fund is to seek long-term capital appreciation. The fund invests 80% of its investable assets in equity-related securities of U.S. companies within a specific group of industries. The fund buys securities of companies in the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and HMOs that derive a substantial portion of their sales from healthcare-related products or services. The fund offers dividends and capital gains annually.
Stock Holding % of Net Assets
| As Of | 02/28/2013 |
| Total Issues | 74 |
| Avg. P/E | 29.40 |
| Avg. P/Book | 5.62 |
| Avg. EPS Growth | 16.67 |
| Avg. Market Value (Mil $) | 31,678 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 0.99 | 0.86 | 0.86 |
| Alpha | 9.33 | 11.60 | 9.73 |
| R Squared | 0.72 | 0.63 | 0.55 |
| Std. Dev. | 17.57 | 20.42 | 17.09 |
| Sharpe | 1.38 | 0.88 | 1.00 |
Shareholder Information
| Manager | David Chan |
| Since | 06/99 |
| Manager Rating | 8.90 |
| Inception Date | 06/30/1999 |
| Shareholders | NA |
| Dividends Paid | A |
| Minimum Initial Investment | $2,500 |
| Minimum Subsequent Investment | $100 |
| IRA Minimum | $1000 |
| IRA Available | Y | Check Writing | N | Phone Invest | Y |
| Phone Exchange | Y | Phone Redeem | Y | Auto Invest | Y |
| Wire Redeem | Y | Wire Fee | Y | Wire Transfer | Y |
Zacks Commentary for PHLAX
Zacks Blog: Top 5 Best Performing Healthcare Mutual Funds Year to Date
Apr 09, 2013
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
Dec 11, 2012
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
Sep 28, 2012
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
Aug 28, 2012
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
Jul 19, 2012
